Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | XENE | CRSP | ||
| Company | Ligand Pharm | Xenon Pharmaceuticals Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 289.11 | 61.41 | 58.73 | ||
| High | 293.37 | 62.51 | 60.90 | ||
| Low | 284.87 | 59.27 | 56.94 | ||
| Last | 287.39 | 59.73 | 58.12 | ||
| Change | -3.32 | -2.59 | -1.69 | ||
| Percent Change | -1.14% | -4.16% | -2.83% | ||
| Volume | 138,900 | 627,200 | 2,910,300 | ||
| 20-Day Average Volume | 275,115 | 631,465 | 1,516,630 | ||
| Previous | 290.71 | 62.32 | 59.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 293.67 | 63.57 | 51.97 | ||
| 20-Day Raw Stochastic | 14.59% | 6.18% | 81.48% | ||
| 20-Day Relative Strength | 48.82 | 43.15 | 60.49 | ||
| Weighted Alpha | +80.67 | +38.67 | +9.30 | ||
| Today's Opinion | 56% Buy | 56% Buy | 24% Buy | ||
| Yesterday's Opinion | 56% Buy | 80% Buy | 16% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.50% since 08/13/26 | -7.01% since 08/13/26 | +7.65% since 08/13/26 | ||
| Low | 282.25 on 08/19/26 | 59.27 on 08/20/26 | 51.80 on 08/18/26 | ||
| High | 298.29 on 08/17/26 | 64.93 on 08/19/26 | 60.90 on 08/20/26 | ||
| 1-Month | |||||
| %Chg | -2.24% since 07/20/26 | -9.55% since 07/20/26 | +23.69% since 07/20/26 | ||
| Low | 282.25 on 08/19/26 | 59.27 on 08/20/26 | 45.89 on 07/28/26 | ||
| High | 317.49 on 08/06/26 | 66.98 on 07/22/26 | 60.90 on 08/20/26 | ||
| 3-Month | |||||
| %Chg | +31.98% since 05/20/26 | +9.24% since 05/20/26 | +19.71% since 05/20/26 | ||
| Low | 215.67 on 05/21/26 | 50.91 on 06/08/26 | 45.89 on 07/28/26 | ||
| High | 326.63 on 07/08/26 | 72.66 on 07/09/26 | 63.45 on 07/06/26 | ||
| 6-Month | |||||
| %Chg | +56.21% since 02/20/26 | +41.44% since 02/20/26 | +8.72% since 02/20/26 | ||
| Low | 178.72 on 02/26/26 | 41.05 on 03/06/26 | 44.12 on 03/30/26 | ||
| High | 326.63 on 07/08/26 | 72.66 on 07/09/26 | 63.45 on 07/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,795,595 | 6,024,225 | 5,783,209 | ||
| Shares Outstanding, K | 19,936 | 96,666 | 96,693 | ||
| Annual Sales, $M | 268,090,000 | 7,500,000 | 3,510,000 | ||
| Annual Net Income, $M | 124,450,000 | -345,910,000 | -581,600,000 | ||
| Last Qtr Sales, $M | 63,690,000 | 0 | 10,180,000 | ||
| Last Qtr Income, $M | 48,510,000 | -110,740,000 | -91,150,000 | ||
| 60-Month Beta | 1.13 | 0.62 | 1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.37 on 08/06/26 | -1.11 on 08/06/26 | -0.94 on 08/03/26 | ||
| Latest Earnings Date | 11/05/26 | 11/02/26 | 11/09/26 | ||
| Most Recent Dividend | 2.500 on 04/03/07 | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.76 | 0.00 | 0.00 | ||